Data_Sheet_1_Plasma Homocysteine as a Potential Marker of Early Renal Function Decline in IgA Nephropathy.docx by Yan-Na Wang (7492079)

“…We also evaluated the association of homocysteine (Hcy) [after adjusted for estimated glomerular filtration rate (eGFR)] with CKD progression event, defined as ESKD or 50% decline in eGFR, in a cohort of 365 patients with IgAN. …”

Serum levels of anti-PspC IgG with increasing age. by Adriano P. Araujo (10136683)

Serum levels of anti-PspA IgG with increasing age. by Adriano P. Araujo (10136683)

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

CSF CCR5+ CD8 T cell frequencies do not decrease during acute SIV infection. by Sonny R. Elizaldi (9684796)

Scientists’ likelihood of using terminology sorted by overall decreasing likelihood ranking. by Jackie M. Getson (13190175)

The treatment with anti-CXCR3 decreases the number of CD8⁺ T cells in the heart. by Camila Pontes Ferreira (6194006)

Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study by Shengnan Chen (3595319)

Percent Decrease in FGM between Oldest (45-49 years) and Youngest (15-19 years) Cohorts of Women over the years in Egypt. by Shatha Elnakib (8901764)

Characterization of lung immune cells before and after influenza challenge in PBS or mRNA-LNP pre-exposed mice. by Zhen Qin (411748)

CD4 T lymphocyte count, CD8 T lymphocyte count (A) and CD4:CD8 ratios (B) analyzed using linear mixed-effects model analysis were not significantly different between Control and Tr... by Wendy L. Wobeser (13047316)

Subjects:

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

Comparison in renal endpoints between low bilirubin group (≤0.5 mg/dL) and high bilirubin group (>0.5 mg/dL) by Kaplan-Meier method and Cox hazard regression models showing the ind... by Erina Eto (13033893)

Subjects:

Comparison in variables between two groups divided by the cut-off value of baseline serum total bilirubin levels. by Erina Eto (13033893)

Subjects:

Characteristics of the study subjects at baseline. by Erina Eto (13033893)

Subjects:

Comparison of annual decline in pulmonary function between patients who were not treated with antifibrotic drugs and patients who were treated with full recommended dose of pirfeni... by Eung Gu Lee (7492319)

Subjects:

PA ameliorates the reduced developmental competence of MGO-challenged COCs. by Shahrzad Ronasi (20933556)

PA ameliorates the reduced developmental competence of MGO-challenged DOs. by Shahrzad Ronasi (20933556)